Literature DB >> 32645862

Neutrophil Extracellular Traps Generation Relates with Early Stage and Vascular Complications in Systemic Sclerosis.

Kevin Didier1,2, Delphine Giusti1,3, Sebastien Le Jan1, Christine Terryn4, Celine Muller1, Bach Nga Pham1,3, Richard Le Naour1, Frank D Antonicelli1, Amelie Servettaz1,2.   

Abstract

Systemic sclerosis (SSc) is a systemic disease characterized by a great clinical and immunological heterogeneity whose pathophysiology is still being unraveled. Recently, innate immunity has been proposed to participate to the pathogenesis of SSc. In this study, we investigated the release of neutrophil extracellular traps (NETs) according to patient phenotype. Polymorphonuclear neutrophils (PMN) from 34 SSc patients and 26 healthy controls were stimulated by serum from SSc or healthy subject. NETs were visualized using epifluorescence microscope after DNA, myeloperoxidase, and Histone H3 tagging. Area of NETs were quantified using an original macro running in ImageJ® software. PMN from SSc patients were significantly more prone to releasing NETs than control PMN after autologous stimulation. PMN from patients with severe vascular complications (pulmonary arterial hypertension, digital ulcers) produced more NETs than PMN from other SSc patients and their aberrant NET production appeared to be sustained over time. In patients with pulmonary interstitial disease or extensive cutaneous fibrosis, NET production was high at an early stage of the disease before progressively decreasing. Both serum factors and PMN activation status were involved in the enhanced production of NETs in SSc. Consequently, neutrophils and especially NETosis represent new physiopathological and therapeutic fields in SSc.

Entities:  

Keywords:  NET; NETosis; PMN; neutrophil extracellular traps; scleroderma; systemic sclerosis

Year:  2020        PMID: 32645862     DOI: 10.3390/jcm9072136

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  7 in total

1.  Blood neutrophil count and neutrophil-to-lymphocyte ratio predict disease progression and mortality in two independent systemic sclerosis cohorts.

Authors:  Nancy Wareing; Vishnu Mohan; Rana Taherian; Elizabeth R Volkmann; Marka A Lyons; Holly Wilhalme; Michael D Roth; Rosa M Estrada-Y-Martin; Brian Skaug; Maureen D Mayes; Donald P Tashkin; Shervin Assassi
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-14       Impact factor: 5.178

2.  Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease.

Authors:  Kazumasa Kase; Satoshi Watanabe; Keigo Saeki; Yuko Waseda; Hazuki Takato; Yukari Ichikawa; Akari Murata; Masahide Yasui; Ohkura Noriyuki; Johsuke Hara; Takashi Sone; Miki Abo; Hideharu Kimura; Kazuo Kasahara
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

3.  Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Authors:  Jianxin Tu; Jinji Jin; Xiaowei Chen; Li Sun; Zhen Cai
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

4.  Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.

Authors:  Gyu-Tae Park; Jung-Won Yoon; Sang-Bin Yoo; Young-Chul Song; Parkyong Song; Hyoung-Kyu Kim; Jin Han; Sung-Jin Bae; Ki-Tae Ha; Natalia P Mishchenko; Sergey A Fedoreyev; Valentin A Stonik; Moon-Bum Kim; Jae-Ho Kim
Journal:  Mar Drugs       Date:  2021-04-23       Impact factor: 5.118

5.  Systemic Sclerosis (SSc) After COVID-19: A Case Report.

Authors:  Arjun Chandra; Bashar Kahaleh
Journal:  Cureus       Date:  2022-03-15

Review 6.  Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response.

Authors:  Rivka C Stone; Vivien Chen; Jamie Burgess; Sukhmani Pannu; Marjana Tomic-Canic
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

7.  N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis.

Authors:  Runa Kuley; Ryan D Stultz; Bhargavi Duvvuri; Ting Wang; Marvin J Fritzler; Roger Hesselstrand; J Lee Nelson; Christian Lood
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.